$CAPR
CAPRICOR THERAPEUTICS, INC.

2015 Q1 Form 10-K Financial Statement

#000114420415016469 Filed on March 16, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 2013 Q4
Revenue $1.788M $4.787M $500.0K
YoY Change 71.64% 851.19% -70.59%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.400M $3.020M $1.300M
YoY Change 64.71% 36.65% 4233.33%
% of Gross Profit
Research & Development $3.807M $7.787M $5.070M
YoY Change 176.93% 49.84% 205.42%
% of Gross Profit
Depreciation & Amortization $24.80K $41.90K $30.00K
YoY Change 283.63% 55.61% 50.0%
% of Gross Profit
Operating Expenses $5.203M $10.80M $6.370M
YoY Change 133.61% 45.89% 279.17%
Operating Profit -$3.415M -$6.018M
YoY Change 188.06% -12.82%
Interest Expense $61.68K $200.5K -$10.00K
YoY Change 143.54% 244.9% -133.33%
% of Operating Profit
Other Income/Expense, Net -$61.41K -$198.6K $330.0K
YoY Change 143.93% -90.01% -176.74%
Pretax Income -$3.480M -$6.220M -$7.460M
YoY Change 187.6% -30.03% 1863.16%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$3.476M -$6.217M -$7.460M
YoY Change 187.14% -30.09% 1863.16%
Net Earnings / Revenue -194.43% -129.87% -1492.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$2.336M -$5.316M -$1.893M
COMMON SHARES
Basic Shares Outstanding 16.22M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.42M $8.030M $2.056M
YoY Change 68.53% 289.81% -52.87%
Cash & Equivalents $6.939M $8.030M $1.730M
Short-Term Investments $15.48M $0.00 $326.5K
Other Short-Term Assets $2.250M $3.220M $1.620M
YoY Change 208.22% 98.77% 3950.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $25.42M $11.61M $3.681M
YoY Change 81.17% 215.49% -29.12%
LONG-TERM ASSETS
Property, Plant & Equipment $250.0K $230.0K $74.19K
YoY Change 52.87% 228.57% 118.56%
Goodwill $1.919M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $70.00K $60.00K $30.00K
YoY Change 40.0% 100.0% -42.24%
Total Long-Term Assets $2.050M $2.020M $1.857M
YoY Change 5.34% 8.6% 706.24%
TOTAL ASSETS
Total Short-Term Assets $25.42M $11.61M $3.681M
Total Long-Term Assets $2.050M $2.020M $1.857M
Total Assets $27.47M $13.63M $5.538M
YoY Change 71.94% 146.03% 2.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.380M $2.130M $2.050M
YoY Change 69.0% 3.9% 1020.73%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.545M $6.300M $2.053M
YoY Change 19.78% 207.32% 287.95%
LONG-TERM LIABILITIES
Long-Term Debt $9.160M $9.160M $3.960M
YoY Change 131.31% 131.31%
Other Long-Term Liabilities $3.450M $4.430M $60.00K
YoY Change -53.25% 7283.33%
Total Long-Term Liabilities $12.60M $13.59M $4.020M
YoY Change 11.12% 238.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.545M $6.300M $2.053M
Total Long-Term Liabilities $12.60M $13.59M $4.020M
Total Liabilities $20.15M $19.88M $6.073M
YoY Change 14.23% 227.51% 1047.61%
SHAREHOLDERS EQUITY
Retained Earnings -$25.79M -$16.10M
YoY Change -65.53%
Common Stock $33.12M $15.56M
YoY Change 283216.87% 150268.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.325M -$6.250M -$534.9K
YoY Change
Total Liabilities & Shareholders Equity $27.47M $13.63M $5.538M
YoY Change 71.94% 146.03% 2.11%

Cashflow Statement

Concept 2015 Q1 2014 2013 Q4
OPERATING ACTIVITIES
Net Income -$3.476M -$6.217M -$7.460M
YoY Change 187.14% -30.09% 1863.16%
Depreciation, Depletion And Amortization $24.80K $41.90K $30.00K
YoY Change 283.63% 55.61% 50.0%
Cash From Operating Activities -$2.050M $960.0K -$5.780M
YoY Change -118.08% -115.64% 5154.55%
INVESTING ACTIVITIES
Capital Expenditures $27.46K $162.7K -$110.0K
YoY Change -70.45% 189.92% 10.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $3.890M
YoY Change -100.0% -100.0% -192.4%
Cash From Investing Activities -$15.52M $140.0K $3.780M
YoY Change 17144.44% -96.3% -187.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $16.45M $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 16.48M 5.210M 3.550M
YoY Change 32.57% -6.82%
NET CHANGE
Cash From Operating Activities -2.050M 960.0K -5.780M
Cash From Investing Activities -15.52M 140.0K 3.780M
Cash From Financing Activities 16.48M 5.210M 3.550M
Net Change In Cash -1.090M 6.310M 1.550M
YoY Change -109.69% 301.91% -350.0%
FREE CASH FLOW
Cash From Operating Activities -$2.050M $960.0K -$5.780M
Capital Expenditures $27.46K $162.7K -$110.0K
Free Cash Flow -$2.077M $797.3K -$5.670M
YoY Change -118.47% -112.87% 56600.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
20815 USD
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Use of Estimates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the reported amounts of revenues and expenses during the reporting period. Management uses its historical records and knowledge of its business in making these estimates. Accordingly, actual results may differ from these estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
0 USD
CY2014Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
360233 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
74187 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
229455 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
257152 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
239752 USD
CY2013Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
1500000 USD
CY2014Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
1500000 USD
CY2014 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
1500000 USD
CY2013Q4 us-gaap Deposit Assets
DepositAssets
25728 USD
CY2014Q4 us-gaap Deposit Assets
DepositAssets
55320 USD
CY2013Q4 us-gaap Assets
Assets
5537907 USD
CY2014Q4 us-gaap Assets
Assets
13632072 USD
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1628925 USD
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1699254 USD
CY2013Q4 capr Accounts Payable And Accrued Expenses Related Party Current
AccountsPayableAndAccruedExpensesRelatedPartyCurrent
423997 USD
CY2014Q4 capr Accounts Payable And Accrued Expenses Related Party Current
AccountsPayableAndAccruedExpensesRelatedPartyCurrent
433712 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4166667 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2052922 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6299633 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0 USD
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4166666 USD
CY2013Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
3961733 USD
CY2014Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
9155857 USD
CY2013Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
58134 USD
CY2014Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
258639 USD
CY2013Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4019867 USD
CY2014Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
13581162 USD
CY2013Q4 us-gaap Liabilities
Liabilities
6072789 USD
CY2014Q4 us-gaap Liabilities
Liabilities
19880795 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
11687 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
11707 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
15552946 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
16054697 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-980 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16098535 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22315127 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-534882 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-6248723 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5537907 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13632072 USD
CY2013Q4 us-gaap Marketable Securities
MarketableSecurities
326494 USD
CY2014 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-50
CY2013Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-50
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014 capr Number Of Rights Offer For Each Share As Per Merger Agreement
NumberOfRightsOfferForEachShareAsPerMergerAgreement
2.07 shares
CY2013Q4 capr Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
2100000 USD
CY2014Q4 capr Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
8000000 USD
CY2014Q1 capr Proceeds From Development Fee
ProceedsFromDevelopmentFee
12500000 USD
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5220800 shares
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5308581 shares
CY2014 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
980 USD
CY2014Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
30000 USD
CY2013Q4 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
6591494 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11707051 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11707051 shares
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1733599 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
332281 shares
CY2014 capr Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
-28400 shares
CY2013 capr Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
251044 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
303881 shares
CY2012Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.38
CY2013Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
17.20
CY2013 capr Class Of Warrant Or Right Granted Weighted Average Exercise Price
ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice
2.27
CY2014 capr Class Of Warrant Or Right Expired Weighted Average Exercise Price
ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice
94.00
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10.02
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.18 pure
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
263593 USD
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
480237 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
39197 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
49930 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11687747 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11687747 shares
CY2014Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2014Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
10800000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
335910 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
232200 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
96750 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
664860 USD
CY2014Q4 capr Leases Monthly Payments For First Twelve Months
LeasesMonthlyPaymentsForFirstTwelveMonths
16620 USD
CY2014Q4 capr Leases Monthly Payments For Second Twelve Months
LeasesMonthlyPaymentsForSecondTwelveMonths
17285 USD
CY2013Q4 capr Proceeds From Development Fee
ProceedsFromDevelopmentFee
12500000 USD
CY2013Q4 capr Additional Milestone Payments To Be Received Contingent Upon Exercise Of Options
AdditionalMilestonePaymentsToBeReceivedContingentUponExerciseOfOptions
325000000 USD
CY2014 us-gaap Payments For Royalties
PaymentsForRoyalties
20000 EUR
CY2013 capr Collaboration Revenue
CollaborationRevenue
0 USD
CY2014 capr Collaboration Revenue
CollaborationRevenue
4166667 USD
CY2013 us-gaap Revenue From Grants
RevenueFromGrants
503233 USD
CY2014 us-gaap Revenue From Grants
RevenueFromGrants
620033 USD
CY2013 us-gaap Revenues
Revenues
503233 USD
CY2014 us-gaap Revenues
Revenues
4786700 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5197178 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7787384 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2208955 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3017301 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
7406133 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
10804685 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-6902900 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-6017985 USD
CY2013 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
-11890 USD
CY2014 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1898 USD
CY2013 us-gaap Interest Expense
InterestExpense
58134 USD
CY2014 us-gaap Interest Expense
InterestExpense
200505 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1989024 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-198607 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-8891924 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-6216592 USD
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8871109 USD
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6215612 USD
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.85
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.53
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10501416 shares
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11696980 shares
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
4894423 USD
CY2013 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
263593 USD
CY2014 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
496939 USD
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4832 USD
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26923 USD
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
41896 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
263593 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
496939 USD
CY2013 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
1401859 USD
CY2014 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
1575165 USD
CY2013 capr Increase Decrease From Grants Receivable
IncreaseDecreaseFromGrantsReceivable
-767163 USD
CY2014 capr Increase Decrease From Grants Receivable
IncreaseDecreaseFromGrantsReceivable
360233 USD
CY2013 capr Increase Decrease In Prepaid And Other Current Assets
IncreaseDecreaseInPrepaidAndOtherCurrentAssets
136589 USD
CY2014 capr Increase Decrease In Prepaid And Other Current Assets
IncreaseDecreaseInPrepaidAndOtherCurrentAssets
12573 USD
CY2013 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
5105 USD
CY2014 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
29592 USD
CY2013 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1072222 USD
CY2014 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
70329 USD
CY2013 capr Increase Decrease In Accounts Payable And Accrued Expenses Related Party
IncreaseDecreaseInAccountsPayableAndAccruedExpensesRelatedParty
184441 USD
CY2014 capr Increase Decrease In Accounts Payable And Accrued Expenses Related Party
IncreaseDecreaseInAccountsPayableAndAccruedExpensesRelatedParty
9715 USD
CY2013 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
58134 USD
CY2014 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
200505 USD
CY2013 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
0 USD
CY2014 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
8333333 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6144001 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
958562 USD
CY2013 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
226998 USD
CY2014 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 USD
CY2013 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
4114045 USD
CY2014 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
327474 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
56115 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
186431 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
3778366 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
141043 USD
CY2013 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3925066 USD
CY2014 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
5200791 USD
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4832 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3925066 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5205623 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1559431 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6305228 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
170106 USD
CY2013 us-gaap Interest Paid
InterestPaid
0 USD
CY2014 us-gaap Interest Paid
InterestPaid
0 USD
CY2013 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2014 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2013 capr Interest On Subscription Receivables
InterestOnSubscriptionReceivables
1 USD
CY2013 capr Proceeds From Subscription Receivables
ProceedsFromSubscriptionReceivables
2212 USD
CY2013 capr Stock Issued During Period Value For Reverse Merger Transaction
StockIssuedDuringPeriodValueForReverseMergerTransaction
3176000 USD
CY2013 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1919000 USD
CY2014 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2013 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
52566 USD
CY2014 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2013Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
3176000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
154616 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
341047 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
80429 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
111592 USD
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11052 USD
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10733 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
49000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
49000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
49000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
49000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
49000 USD
CY2013Q4 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
17416 USD
CY2014Q4 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
14181 USD
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
CY2013Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
664 USD
CY2013Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
25639 USD
CY2013Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
1500000 USD
CY2013Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
269303 USD
CY2013Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
1257000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
1919000 USD
CY2014 dei Entity Registrant Name
EntityRegistrantName
CAPRICOR THERAPEUTICS, INC.
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0001133869
CY2014 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013 capr Class Of Warrant Or Right Assumed From Merger
ClassOfWarrantOrRightAssumedFromMerger
81237 shares
CY2013 capr Class Of Warrant Or Right Assumed From Merger Weighted Average Exercise Price
ClassOfWarrantOrRightAssumedFromMergerWeightedAverageExercisePrice
63.33
CY2013 capr Class Of Warrant Or Right Cancelled
ClassOfWarrantOrRightCancelled
-1733599 shares
CY2013 capr Class Of Warrant Or Right Cancelled Weighted Average Exercise Price
ClassOfWarrantOrRightCancelledWeightedAverageExercisePrice
3.38
CY2014Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
5004700 shares
CY2014 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y5M1D
CY2014Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.75
CY2014Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
3534533 shares
CY2014 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P7Y29D
CY2014Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.47
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5004700 shares
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014Q2 dei Entity Public Float
EntityPublicFloat
13677814 USD
CY2014 dei Trading Symbol
TradingSymbol
CAPR
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16221985 shares

Files In Submission

Name View Source Status
0001144204-15-016469-index-headers.html Edgar Link pending
0001144204-15-016469-index.html Edgar Link pending
0001144204-15-016469.txt Edgar Link pending
0001144204-15-016469-xbrl.zip Edgar Link pending
capr-20141231.xml Edgar Link completed
capr-20141231.xsd Edgar Link pending
capr-20141231_cal.xml Edgar Link unprocessable
capr-20141231_def.xml Edgar Link unprocessable
capr-20141231_lab.xml Edgar Link unprocessable
capr-20141231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v403079_10k.htm Edgar Link pending
v403079_ex21-1.htm Edgar Link pending
v403079_ex23-1.htm Edgar Link pending
v403079_ex31-1.htm Edgar Link pending
v403079_ex31-2.htm Edgar Link pending
v403079_ex32-1.htm Edgar Link pending
v403079_ex32-2.htm Edgar Link pending